ConductScience.org, home

Trial · NCT01652326

Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome

NCT01652326, Completed, University of Pittsburgh

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome. Trials, record NCT01652326. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01652326

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome
NCT number
NCT01652326
Status
Completed
Enrollment
792 participants, actual
Lead sponsor
University of Pittsburgh
Conditions
Alcohol Withdrawal Syndrome
Interventions
Diazepam
First posted
2012-07-30
Last updated
2016-01-13

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIdentify those risk factors predictive of benzodiazepine-resistant alcohol withdrawal syndromeup to 38 months
SecondaryDrug utilization of phenobarbital, propofol, dexmedetomidine, and ketamine in benzodiazepine-resistant alcohol withdrawal syndromeUp to 38 monthsWill compare the frequency, duration and dosages of the above agents when used for benzodiazepine-resistant alcohol withdrawal
SecondaryEffectiveness of phenobarbital, propofol, dexmedetomidine, and ketamine in benzodiazepine-resistant alcohol withdrawalUp to 38 months
Comparative markers will include: 1. Presence or absence of the following: delirium tremens, hallucinosis, seizures, or arrhythmias 2. Indication and duration of mechanical intubation 3. Nosocomial infection rates 4. ICU length of stay
SecondaryTolerability of phenobarbital, propofol, dexmedetomidine, and ketamine in benzodiazepine-resistant alcohol withdrawalUp to 38 monthsComparative markers will include: 1. Rikers Sedation Scale Assessments 2. Hypotension 3. Hypertriglyceridemia/Pancreatitis 4. Drug induced hallucinosis or seizures

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01652326

GET https://conductscience.org/api/trials/v1/NCT01652326/registered